Studies Currently Enrolling
Review the list of ongoing clinical trials. If you find one that might be a fit, you can take a brief questionnaire to see if you qualify.
Currently enrolling
MK-2214
Slow early Alzheimer's disease progression
- Age 50-85
- Early Alzheimer's Disease
- Infusion
- Study zone: Southern California + North Central Florida
View details
Currently enrolling
PRECISE-AD
Evaluating a new treatment for early Alzheimer's
- Age 50 and older
- Early Alzheimer's Disease
- Infusion
- Study zone: Southern California
View details
Currently enrolling
TRONTIER-1
Assess delaying of the progression to symptomatic stages
- Age 50-90
- Early Alzheimer's Disease
- Infusion
- Study zone: Southern California + Central Florida
View details
Currently enrolling
MINDSET-2
Evaluating a treatment for cognitive impairment in AD
- Age 60-85
- Alzheimer's disease
- Oral medication
- Study zone: Southern California + North Central Florida
View details
Currently enrolling
ANVS-25001
Evaluating a treatment for cognitive impairment in AD
- Age 55-85
- Alzheimer's disease
- Oral medication
- Study zone: Central Florida + Greater Philadelphia
View details
Currently enrolling
VHB937
Evaluating a new treatment for early Alzheimer's
- Age 50-85
- Early Alzheimer's Disease
- Infusion
- Study zone: North Central Florida
View details
Currently enrolling
BALANCE-AAD-1
Evaluating a treatment for agitation in Alzheimer's Disease
- Age 55–90
- Agitation in Alzheimer's Disease
- Oral medication
- Study zone: Greater Omaha + Greater Austin (TX)
View details